Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function

Kylie BR Belchamber, Catherine MR Thomas, Amy E Dunne, Peter J Barnes, Louise E Donnelly Airway Disease Section, National Heart and Lung Institute, Dovehouse Street, Imperial College London, London, UK Background: Inhaled corticosteroid use is associated with increased rates of pneumonia in COPD p...

Full description

Bibliographic Details
Main Authors: Belchamber KBR, Thomas CMR, Dunne AE, Barnes PJ, Donnelly LE
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/comparison-of-fluticasone-propionate-and-budesonide-on-copd-macrophage-peer-reviewed-article-COPD
_version_ 1818964605611802624
author Belchamber KBR
Thomas CMR
Dunne AE
Barnes PJ
Donnelly LE
author_facet Belchamber KBR
Thomas CMR
Dunne AE
Barnes PJ
Donnelly LE
author_sort Belchamber KBR
collection DOAJ
description Kylie BR Belchamber, Catherine MR Thomas, Amy E Dunne, Peter J Barnes, Louise E Donnelly Airway Disease Section, National Heart and Lung Institute, Dovehouse Street, Imperial College London, London, UK Background: Inhaled corticosteroid use is associated with increased rates of pneumonia in COPD patients. The underlying mechanism is unknown, although recent data suggest that pneumonia is more frequent in patients treated with fluticasone propionate (FP) than budesonide. Macrophages and neutrophils from COPD patients are deficient in clearing bacteria, and this might explain increased bacterial colonization in COPD. Inhaled corticosteroid may further suppress this response; therefore, we examined the effect of FP and budesonide on phagocytosis of common respiratory pathogens by monocyte-derived macrophages (MDMs) and neutrophils.Methods: MDMs from COPD patients (n=20–24) were preincubated with FP or budesonide for 1 or 18 hours, after which phagocytosis of fluorescently labeled inert beads or heat-killed Haemophilus influenzae/Streptococcus pneumoniae were measured fluorimetrically after 1 or 4 hours. Additionally, CXCL8, IL6, and TNFα concentrations in supernatants by ELISA, MDM-scavenger-receptor expression by flow cytometry, and MDM ability to kill bacteria were measured. Neutrophils from COPD patients (n=8) were preincubated with corticosteroids for 1 hour and bacteria phagocytosis measured by flow cytometry.Results: After 1 hour’s preincubation, neither corticosteroid altered MDM phagocytosis of beads or H. influenzae; however, budesonide (10-7 M) increased S. pneumoniae phagocytosis by 23% (P<0.05). After 18 hours’ preincubation, neither corticosteroid altered MDM phagocytosis of any prey, although H. influenzae phagocytosis by budesonide was significantly greater compared to FP at 10-6 and 10-5 M (P<0.05). The 1-hour preincubation with either corticosteroid inhibited bacteria-induced CXCL8 release (at 10-7 and 10-5 M, P<0.05); however, this effect was lost at 18-hour preincubation. There was no change in receptor expression, bacterial killing, or neutrophil phagocytosis by either corticosteroid.Conclusion: These data suggest that dissolved FP and budesonide do not have an overall effect on MDM or neutrophil phagocytosis of bacteria. Keywords: COPD, macrophage, neutrophil, fluticasone propionate, budesonide
first_indexed 2024-12-20T13:03:46Z
format Article
id doaj.art-6e07f8f5209941acaf8269fa031d08ac
institution Directory Open Access Journal
issn 1178-2005
language English
last_indexed 2024-12-20T13:03:46Z
publishDate 2018-09-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-6e07f8f5209941acaf8269fa031d08ac2022-12-21T19:39:50ZengDove Medical PressInternational Journal of COPD1178-20052018-09-01Volume 132883289740655Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil functionBelchamber KBRThomas CMRDunne AEBarnes PJDonnelly LEKylie BR Belchamber, Catherine MR Thomas, Amy E Dunne, Peter J Barnes, Louise E Donnelly Airway Disease Section, National Heart and Lung Institute, Dovehouse Street, Imperial College London, London, UK Background: Inhaled corticosteroid use is associated with increased rates of pneumonia in COPD patients. The underlying mechanism is unknown, although recent data suggest that pneumonia is more frequent in patients treated with fluticasone propionate (FP) than budesonide. Macrophages and neutrophils from COPD patients are deficient in clearing bacteria, and this might explain increased bacterial colonization in COPD. Inhaled corticosteroid may further suppress this response; therefore, we examined the effect of FP and budesonide on phagocytosis of common respiratory pathogens by monocyte-derived macrophages (MDMs) and neutrophils.Methods: MDMs from COPD patients (n=20–24) were preincubated with FP or budesonide for 1 or 18 hours, after which phagocytosis of fluorescently labeled inert beads or heat-killed Haemophilus influenzae/Streptococcus pneumoniae were measured fluorimetrically after 1 or 4 hours. Additionally, CXCL8, IL6, and TNFα concentrations in supernatants by ELISA, MDM-scavenger-receptor expression by flow cytometry, and MDM ability to kill bacteria were measured. Neutrophils from COPD patients (n=8) were preincubated with corticosteroids for 1 hour and bacteria phagocytosis measured by flow cytometry.Results: After 1 hour’s preincubation, neither corticosteroid altered MDM phagocytosis of beads or H. influenzae; however, budesonide (10-7 M) increased S. pneumoniae phagocytosis by 23% (P<0.05). After 18 hours’ preincubation, neither corticosteroid altered MDM phagocytosis of any prey, although H. influenzae phagocytosis by budesonide was significantly greater compared to FP at 10-6 and 10-5 M (P<0.05). The 1-hour preincubation with either corticosteroid inhibited bacteria-induced CXCL8 release (at 10-7 and 10-5 M, P<0.05); however, this effect was lost at 18-hour preincubation. There was no change in receptor expression, bacterial killing, or neutrophil phagocytosis by either corticosteroid.Conclusion: These data suggest that dissolved FP and budesonide do not have an overall effect on MDM or neutrophil phagocytosis of bacteria. Keywords: COPD, macrophage, neutrophil, fluticasone propionate, budesonidehttps://www.dovepress.com/comparison-of-fluticasone-propionate-and-budesonide-on-copd-macrophage-peer-reviewed-article-COPDCOPDmacrophageneutrophilfluticasone propionatebudesonide
spellingShingle Belchamber KBR
Thomas CMR
Dunne AE
Barnes PJ
Donnelly LE
Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
International Journal of COPD
COPD
macrophage
neutrophil
fluticasone propionate
budesonide
title Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
title_full Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
title_fullStr Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
title_full_unstemmed Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
title_short Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
title_sort comparison of fluticasone propionate and budesonide on copd macrophage and neutrophil function
topic COPD
macrophage
neutrophil
fluticasone propionate
budesonide
url https://www.dovepress.com/comparison-of-fluticasone-propionate-and-budesonide-on-copd-macrophage-peer-reviewed-article-COPD
work_keys_str_mv AT belchamberkbr comparisonoffluticasonepropionateandbudesonideoncopdmacrophageandneutrophilfunction
AT thomascmr comparisonoffluticasonepropionateandbudesonideoncopdmacrophageandneutrophilfunction
AT dunneae comparisonoffluticasonepropionateandbudesonideoncopdmacrophageandneutrophilfunction
AT barnespj comparisonoffluticasonepropionateandbudesonideoncopdmacrophageandneutrophilfunction
AT donnellyle comparisonoffluticasonepropionateandbudesonideoncopdmacrophageandneutrophilfunction